Zentalis Pharmaceuticals Statistics

Total Valuation

ZNTL has a market cap or net worth of $107.48 million. The enterprise value is -$154.63 million.

Market Cap	107.48M
Enterprise Value	-154.63M

Important Dates

The last earnings date was Wednesday, August 6, 2025, after market close.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

ZNTL has 72.14 million shares outstanding. The number of shares has increased by 0.90% in one year.

Current Share Class	72.14M
Shares Outstanding	72.14M
Shares Change (YoY)	+0.90%
Shares Change (QoQ)	+0.44%
Owned by Insiders (%)	1.59%
Owned by Institutions (%)	56.01%
Float	49.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.97
Forward PS	n/a
PB Ratio	0.39
P/TBV Ratio	0.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.99, with a Debt / Equity ratio of 0.15.

Current Ratio	7.99
Quick Ratio	7.78
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -49.55% and return on invested capital (ROIC) is -28.86%.

Return on Equity (ROE)	-49.55%
Return on Assets (ROA)	-25.41%
Return on Invested Capital (ROIC)	-28.86%
Return on Capital Employed (ROCE)	-54.83%
Revenue Per Employee	$161,837
Profits Per Employee	-$980,620
Employee Count	166
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	-232,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.66% in the last 52 weeks. The beta is 1.72, so ZNTL's price volatility has been higher than the market average.

Beta (5Y)	1.72
52-Week Price Change	-50.66%
50-Day Moving Average	1.38
200-Day Moving Average	2.05
Relative Strength Index (RSI)	58.69
Average Volume (20 Days)	550,747

Short Selling Information

The latest short interest is 4.71 million, so 6.53% of the outstanding shares have been sold short.

Short Interest	4.71M
Short Previous Month	4.77M
Short % of Shares Out	6.53%
Short % of Float	9.42%
Short Ratio (days to cover)	5.73

Income Statement

In the last 12 months, ZNTL had revenue of $26.87 million and -$162.78 million in losses. Loss per share was -$2.28.

Revenue	26.87M
Gross Profit	26.87M
Operating Income	-171.43M
Pretax Income	-194.35M
Net Income	-162.78M
EBITDA	-170.37M
EBIT	-171.43M
Loss Per Share	-$2.28

Full Income Statement

Balance Sheet

The company has $303.43 million in cash and $41.32 million in debt, giving a net cash position of $262.11 million or $3.63 per share.

Cash & Cash Equivalents	303.43M
Total Debt	41.32M
Net Cash	262.11M
Net Cash Per Share	$3.63
Equity (Book Value)	274.50M
Book Value Per Share	3.81
Working Capital	272.57M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-151.09M
Capital Expenditures	n/a
Free Cash Flow	-151.09M
FCF Per Share	-$2.09

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-638.12%
Pretax Margin	-606.79%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ZNTL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.90%
Shareholder Yield	-0.90%
Earnings Yield	-151.45%
FCF Yield	-140.57%

Dividend Details

Analyst Forecast

The average price target for ZNTL is $8.46, which is 467.79% higher than the current price. The consensus rating is "Buy".

Price Target	$8.46
Price Target Difference	467.79%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	21.64%
EPS Growth Forecast (5Y)	-31.40%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ZNTL has an Altman Z-Score of -3.65 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.65
Piotroski F-Score	2